Tomeki

Trial of [beta]-napthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders

Trial of [beta]-napthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders

By C. Gardikas

0 (0 Ratings)
0 Want to read0 Currently reading0 Have read

Publish Date

1951

Publisher

Lancet Office

Language

eng

Pages

-

1-1 of 1 Editions

Trial of [beta]-napthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders

View Trial of [beta]-napthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders